CNCR vs. ROBO

Last updated Jun 3, 2026

CNCR (Loncar Cancer Immunotherapy ETF) and ROBO (ROBO Global Robotics & Automation Index ETF) are both exchange-traded funds - CNCR is a Health & Biotech Equities fund tracking the Loncar Cancer Immunotherapy Index, while ROBO is a Robotics fund tracking the ROBO Global Robotics and Automation TR Index. Both are passively managed. CNCR charges 0.79%/yr vs 0.95%/yr for ROBO.

Performance

CNCR vs. ROBO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Loncar Cancer Immunotherapy ETF (CNCR) and ROBO Global Robotics & Automation Index ETF (ROBO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

ROBO

• 1D: 0.86%
• 1M: 10.25%
• YTD: 30.34%
• 6M: 33.71%
• 1Y: 61.59%
• 3Y*: 17.43%
• 5Y*: 7.60%
• 10Y*: 13.74%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CNCR vs. ROBO - Yearly Performance Comparison

	2026 (YTD)
CNCR Loncar Cancer Immunotherapy ETF	0.00%
ROBO ROBO Global Robotics & Automation Index ETF	21.41%

CNCR vs. ROBO - Sectors Allocation Comparison

Sectors	CNCR	ROBO
Healthcare	96.6%	4.9%
Financial Services	3.3%	2.2%
Basic Materials	-	-
Communication Services	-	1.1%
Consumer Cyclical	-	3.1%
Consumer Defensive	-	1.3%
Energy	-	-
Industrials	-	46.8%
Real Estate	-	-
Technology	-	41.9%
Utilities	-	-

Return for Risk

CNCR vs. ROBO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ROBO

ROBO Risk / Return Rank: 76
ROBO Sharpe Ratio Rank: 82
ROBO Sortino Ratio Rank: 77
ROBO Omega Ratio Rank: 74
ROBO Calmar Ratio Rank: 71
ROBO Martin Ratio Rank: 74

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CNCR vs. ROBO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Loncar Cancer Immunotherapy ETF (CNCR) and ROBO Global Robotics & Automation Index ETF (ROBO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	CNCR	ROBO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	2.69	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.32	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.60	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.50	—

Drawdowns

CNCR vs. ROBO - Drawdown Comparison

The maximum CNCR drawdown since its inception was 0.00%, smaller than the maximum ROBO drawdown of -43.65%. Use the drawdown chart below to compare losses from any high point for CNCR and ROBO.

Drawdown Indicators

	CNCR	ROBO	Difference
Max Drawdown Largest peak-to-trough decline	0.00%	-43.65%	+43.65%
Max Drawdown (1Y) Largest decline over 1 year	—	-17.35%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-27.92%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-43.65%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-43.65%	—
Current Drawdown Current decline from peak	0.00%	0.00%	0.00%
Average Drawdown Average peak-to-trough decline	0.00%	-12.94%	+12.94%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	4.33%	—

Volatility

Volatility by Period

	CNCR	ROBO	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	7.69%	—
Volatility (6M) Calculated over the trailing 6-month period	—	18.05%	—
Volatility (1Y) Calculated over the trailing 1-year period	0.00%	22.99%	-22.99%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.00%	23.64%	-23.64%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.00%	23.16%	-23.16%

CNCR vs. ROBO - Expense Ratio Comparison

CNCR has a 0.79% expense ratio, which is lower than ROBO's 0.95% expense ratio.

Dividends

CNCR vs. ROBO - Dividend Comparison

CNCR has not paid dividends to shareholders, while ROBO's dividend yield for the trailing twelve months is around 0.32%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CNCR Loncar Cancer Immunotherapy ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROBO ROBO Global Robotics & Automation Index ETF	0.32%	0.42%	0.55%	0.05%	0.00%	0.18%	0.20%	0.37%	0.37%	0.02%	0.19%	0.28%

Frequently Asked Questions

Which ETF is better, CNCR or ROBO?

On fees, CNCR is cheaper at 0.79% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, CNCR or ROBO?

CNCR is cheaper with a 0.79% expense ratio, compared with 0.95% for ROBO.

Which ETF pays a higher dividend yield, CNCR or ROBO?

ROBO has the higher dividend yield at 0.32%, compared with 0.00% for CNCR.

What is the main difference between CNCR and ROBO?

CNCR is categorized as Health & Biotech Equities, while ROBO is Robotics. CNCR tracks Loncar Cancer Immunotherapy Index, while ROBO tracks ROBO Global Robotics and Automation TR Index. Their fees differ too: 0.79% for CNCR and 0.95% for ROBO.